CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 75 enrolled
Drug / intervention
Sana Pain Reliever +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04280562
NCT04280562N/ACompleted

Extended Home-use Trial of a Novel Device to Reduce Chronic Neuropathic Pain

Icahn School of Medicine at Mount Sinai·interventional·Posted Feb 21, 2020·Updated Nov 4, 2025

In Brief

A clinical study evaluating Sana Pain Reliever and Sham SPR for Neuropathic Pain and 2 related conditions. Completed, enrolled 75 participants across 1 site.

Detailed Summary

Randomized controlled trial to assess the effectiveness and patient perception of the benefit of the Sana Pain Reliever in individuals with chronic neuropathic pain.The study is fully remote with four study visits taking place over teleconferencing and the study devices mailed to the participants to use at home for 8-14 weeks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsSana Health, Inc.

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedFeb 21, 2020
Enrollment StartJan 31, 2020
Primary CompletionFeb 21, 2023
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 6.4 years ago

Interventions

Sana Pain Relieverdevice

Participants will receive the SPR device and a tablet with instructions of how to use the device and how to answer the questionnaires on the tablet mobile application. Each session with the device will last 16 minutes and run under the device's normal settings. The session consists of periods of light and sounds (beeps). Participants will be instructed to use the device each day at the end of the day prior to going to sleep and whenever they experience heightened pain during the day.

Sham SPRdevice

Participants will receive the SPR device and a tablet with instructions of how to use the device and how to answer the questionnaires on the tablet mobile application. Each session with the device will last 16 minutes and run under the device's sham settings. The session consists of periods of light and sounds (beeps). Participants will be instructed to use the device each day at the end of the day prior to going to sleep and whenever they experience heightened pain during the day.